Hubbry Logo
ErgotErgotMain
Open search
Ergot
Community hub
Ergot
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Ergot
Ergot
from Wikipedia

Ergot
Claviceps purpurea
Scientific classification Edit this classification
Kingdom: Fungi
Division: Ascomycota
Class: Sordariomycetes
Order: Hypocreales
Family: Clavicipitaceae
Genus: Claviceps
Tul., 1853
Species

About 50, including:
Claviceps africana
Claviceps fusiformis
Claviceps paspali
Claviceps purpurea
Claviceps sorghi
Claviceps zizaniae
Claviceps lutea Oryza sativa

Synonyms
List
  • Balansiella Henn. (1904)
  • Ergotaetia E.J. Quekett (1841)
  • Kentrosporium Wallr. (1844) [1842-44]
  • Mothesia Oddo & Tonolo (1967)
  • Spermoedia Fr. (1822)
  • Sphacelia Lév. (1827)
  • Ustilaginula Clem. (1909)
  • Ustilagopsis Speg. (1880)

Ergot (/ˈɜːrɡət/ UR-gət) or ergot fungi refers to a group of fungi of the genus Claviceps.[1]

The most prominent member of this group is Claviceps purpurea ("rye ergot fungus"). This fungus grows on rye and related plants, and produces alkaloids that can cause ergotism in humans and other mammals who consume grains contaminated with its fruiting structure (called ergot sclerotium).[2][3]

Claviceps includes about 50 known species, mostly in the tropical regions. Economically significant species include C. purpurea (parasitic on grasses and cereals), C. fusiformis (on pearl millet, buffel grass), C. paspali (on dallis grass), C. africana[4] (on sorghum) and C. lutea (on paspalum).[5] C. purpurea most commonly affects outcrossing species such as rye (its most common host), as well as triticale, wheat and barley. It affects oats only rarely.

C. purpurea has at least three races or varieties, which differ in their host specificity:[6]

  • G1 – land grasses of open meadows and fields;
  • G2 – grasses from moist, forest and mountain habitats;
  • G3 (C. purpurea var. spartinae) – salt marsh grasses (Spartina, Distichlis).

Life cycle

[edit]

An ergot kernel, called a sclerotium, develops when a spore of fungal species of the genus Claviceps infects a floret of flowering grass or cereal. The infection process mimics a pollen grain growing into an ovary during fertilization. Infection requires that the fungal spore have access to the stigma; consequently, plants infected by Claviceps are mainly outcrossing species with open flowers, such as rye (Secale cereale) and ryegrasses (genus Lolium). The proliferating fungal mycelium then destroys the plant ovary and connects with the vascular bundle originally intended for seed nutrition. The first stage of ergot infection manifests itself as a white soft tissue (known as sphacelia) producing sugary honeydew, which often drops out of the infected grass florets. This honeydew contains millions of asexual spores (conidia), which insects disperse to other florets. Later, the sphacelia convert into a hard dry sclerotium inside the husk of the floret. At this stage, alkaloids and lipids accumulate in the sclerotium.

Claviceps species from tropic and subtropic regions produce macro- and microconidia in their honeydew. Macroconidia differ in shape and size between the species, whereas microconidia are rather uniform, oval to globose (5×3 μm). Macroconidia are able to produce secondary conidia. A germ tube emerges from a macroconidium through the surface of a honeydew drop and a secondary conidium of an oval to pearlike shape is formed, to which the contents of the original macroconidium migrates. Secondary conidia form a white, frost-like surface on honeydew drops and spread via the wind. No such process occurs in Claviceps purpurea, Claviceps grohii, Claviceps nigricans and Claviceps zizaniae, all from northern temperate regions.

When a mature sclerotium drops to the ground, the fungus remains dormant until proper conditions (such as the onset of spring or a rain period) trigger its fruiting phase. It germinates, forming one or several fruiting bodies with heads and stipes, variously coloured (resembling a tiny mushroom). In the head, threadlike sexual spores form, which are ejected simultaneously when suitable grass hosts are flowering.

Ergot infection causes a reduction in the yield and quality of grain and hay, and if livestock eat infected grain or hay it may cause a disease called ergotism. Black and protruding sclerotia of C. purpurea are well known. However, many tropical ergots have brown or greyish sclerotia, mimicking the shape of the host seed. For this reason, the infection is often overlooked.

Insects, including flies and moths, carry conidia of Claviceps species, but it is unknown whether insects play a role in spreading the fungus from infected to healthy plants.[7]

Evolution

[edit]

Regarding the evolution of plant parasitism in the Clavicipitaceae, an amber fossil discovered in 2020 preserves a grass spikelet and an ergot-like parasitic fungus. The fossil shows that the original hosts of the Clavicipitaceae could have been grasses. The discovery also establishes a minimum time for the conceivable presence of psychotropic compounds in fungi.[8][9] Several evolutionary processes have acted to diversify the array of ergot alkaloids produced by fungi; these differences in enzyme activities are evident at the levels of substrate specificity (LpsA), product specification (EasA, CloA) or both (EasG and possibly CloA).[10] The "old yellow enzyme", EasA, presents an outstanding example. This enzyme catalyzes reduction of the C8=C9 double-bond in chanoclavine I, but EasA isoforms differ in whether they subsequently catalyze reoxidation of C8–C9 after rotation.[10] This difference distinguishes most Clavicipitaceae from Trichocomaceae, but in Clavicipitaceae it is also the key difference dividing the branch of classical ergot alkaloids from dihydroergot alkaloids, the latter often being preferred for pharmaceuticals due to their relatively few side effects.[10]

Effects on humans, other mammals and LSD

[edit]
Ergot-derived drug to stop postpartum bleeding

The ergot sclerotium contains high concentrations (up to 2% of dry mass) of the alkaloid ergotamine, a complex molecule consisting of a tripeptide-derived cyclol-lactam ring connected via amide linkage to a lysergic acid (ergoline) moiety, and other alkaloids of the ergoline group that are biosynthesized by the fungus.[11] Ergot alkaloids have a wide range of biological activities including effects on circulation and neurotransmission.[12]

Ergot alkaloids are classified as:

  1. derivatives of 6,8-dimethylergoline and
  2. lysergic acid derivatives.[13]

Ergotism is the name for sometimes severe pathological syndromes affecting humans or other animals that have ingested plant material containing ergot alkaloid, such as ergot-contaminated grains.

The Hospital Brothers of St. Anthony, an order of monks established in 1095, specialized in treating ergotism victims[14] with balms containing tranquilizing and circulation-stimulating plant extracts. The common name for ergotism is "St. Anthony's fire",[14] in reference to this order of monks and the severe burning sensations in the limbs which was one of the symptoms.[15]

There are two types of ergotism. The first is characterized by muscle spasms, fever and hallucinations and the victims may appear dazed, be unable to speak, become manic, or have other forms of paralysis or tremors, and suffer from hallucinations and other distorted perceptions.[16] This is caused by serotonergic stimulation of the central nervous system by some of the alkaloids.[16]

The second type of ergotism is marked by violent burning, absent peripheral pulses and shooting pain of the poorly vascularized distal organs, such as the fingers and toes,[16] and are caused by effects of ergot alkaloids on the vascular system due to vasoconstriction, sometimes leading to gangrene and loss of limbs due to severely restricted blood circulation.

The psychoactive properties of the ergot alkaloids may also cause hallucinations and attendant irrational behaviour, convulsions, and even death.[11][12] Other symptoms include strong uterine contractions, nausea, seizures, high fever, vomiting, loss of muscle strength and unconsciousness.

Since the Middle Ages, controlled doses of ergot were used to induce abortions and to stop maternal bleeding after childbirth.[17]

Klotz offers a detailed overview of the toxicities in mammalian livestock, stating that the activities are attributable to antagonism or agonism of neurotransmitters, including dopamine, serotonin and norepinephrine. He also states that the adrenergic blockage by ergopeptines (e.g., ergovaline or ergotamine) leads to potent and long-term vasoconstriction, and can result in reduced blood flow resulting in intense burning pain (St. Anthony's fire), edema, cyanosis, dry gangrene and even loss of hooves in cattle or limbs in humans. Reduced prolactin due to ergot alkaloid activity on dopamine receptors in the pituitary is also common in livestock. Reduced serum prolactin is associated with various reproductive problems in cattle, and especially in horses, including agalactia and poor conception, and late-term losses of foals and sometimes mares due to dystocia and thickened placentas.[10] Although both gangrenous and convulsive symptoms are seen in naturally occurring ergotism resulting from the ingestion of fungus infected rye, only gangrenous ergotism has been reported following the excessive ingestion of ergotamine tartrate.[18]

Ergot extract has been used in pharmaceutical preparations, including ergot alkaloids in products such as Cafergot (containing caffeine and ergotamine[17] or ergoline) to treat migraine headaches, and ergometrine, used to induce uterine contractions and to control bleeding after childbirth.[19] Clinical ergotism as seen today results almost exclusively from the excessive intake of ergotamine tartrate in the treatment of migraine headache.[18]

In addition to ergot alkaloids, Claviceps paspali also produces tremorgens (paspalitrem) causing "paspalum staggers" in cattle.[20] The fungi of the genera Penicillium and Aspergillus also produce ergot alkaloids, notably some isolates of the human pathogen Aspergillus fumigatus,[21] and have been isolated from plants in the family Convolvulaceae, of which morning glory is best known. The causative agents of most ergot poisonings are the ergot alkaloid class of fungal metabolites, though some ergot fungi produce distantly related indole-diterpene alkaloids that are tremorgenic.[10]

Ergot does not contain lysergic acid diethylamide (LSD) but instead contains lysergic acid as well as its precursor,[22] ergotamine. Lysergic acid is a precursor for the synthesis of LSD. Their realized and hypothesized medicinal uses have encouraged intensive research since the 1950s culminating on the one hand in development of drugs both legal (e.g., bromocriptine) and illegal (e.g., LSD), and on the other hand in extensive knowledge of the enzymes, genetics and diversity of ergot alkaloid biosynthetic pathways.[10]

The January 4, 2007 issue of the New England Journal of Medicine includes a paper that documents a British study of more than 11,000 Parkinson's disease patients. The study found that two ergot-derived drugs, pergolide and cabergoline, commonly used to treat Parkinson's Disease may increase the risk of leaky heart valves by up to 700%.[23]

History

[edit]
Ergot on wheat heads

Ergotism is the earliest recorded example of mycotoxicosis, or poisoning caused by toxic molds.[24] Early references to ergotism date back as far as 600 BC, an Assyrian tablet referred to it as a "noxious pustule in the ear of grain."[25] In 350 BC, the Parsees described "noxious grasses that cause pregnant women to drop the womb and die in childbed."[25] In ancient Syria, ergot was called "Daughter of Blood."[26] Radulf Glaber described an ailment he called "hidden fire," or ignus ocultus, in which a burning of the limb is followed by its separation from the body, often consuming the victim in one night.[26] In 1588, Johannes Thallius wrote that it is called "Mother of Rye," or rockenmutter, and is used to halt bleeding.[26]

Human poisoning due to the consumption of rye bread made from ergot-infected grain was common in Europe in the Middle Ages. The first mention of a plague of gangrenous ergotism in Europe comes from Germany in 857; following this, France and Scandinavia experienced similar outbreaks;[27] England is noticeably absent from the historical regions affected by ergotism as its main source of food was wheat, which is resistant to ergot fungi.[26] In 994, a massive outbreak potentially attributed to ergotism caused 40,000 deaths in the regions of Aquitaine, Limousin, Périgord and Angoumois in France.[24] In Hesse, in 1596, Wendelin Thelius was one of the first to attribute ergotism poisoning to grain.[27] In 1778, S. Tessier, observing a huge epidemic in Sologne, France, in which more than 8,000 people died, recommended drainage of fields, compulsory cleaning of grain, and the substitution of potatoes for affected grain.[27]

In 1722, the Russian Tsar Peter the Great was thwarted in his campaign against the Ottoman Empire as his army, traveling down the Terek steppe, was struck by ergotism and was forced to retreat in order to find edible grains. A diary entry from the time notes that as soon as people ate the poisoned bread, they became dizzy, with such strong nerve contractions that those who did not die on the first day found their hands and feet falling off, akin to frostbite.[24] The outbreak was known as Saint Anthony's fire,[14] or ignis sacer.

Some historical events, such as the Great Fear in France at the outset of the French Revolution, have been linked to ergot poisoning.[28]

Saint Anthony's fire and the Antonites

[edit]

Saint Anthony was a 3rd Century Egyptian ascetic who lived by the Red Sea and was known for long fasting in which he confronted terrible visions and temptations sent from the Devil.[27] He was credited by two noblemen for assisting them in recovery from the disease; they subsequently founded the Order of St. Anthony in his honor.[26] Anthony was a popular subject for art in the Middle Ages, and his symbol is a large blue "T" sewn onto the shoulder of the order's monks, symbolizing the crutch used by the ill and injured.[29]

The Order of St. Anthony, whose members were known as Antonites, grew quickly, and hospitals spread through France, Germany and Scandinavia and gained wealth and power as grateful patrons bestowed money and charitable goods on the hospitals.[26] By the end of the Middle Ages, there were 396 settlements and 372 hospitals owned by the order,[29] and pilgrimages to such hospitals became popular, as well as the donation of limbs lost to ergotism, which were displayed near shrines to the saint.[26] These hagiotherapeutic centers were the first specialized European medical welfare systems, and the friars of the order were knowledgeable about treatment of ergotism and the horrifying effects of the poison.[29] The sufferers would receive ergot-free meals, wines containing vasodilating and analgesic herbs, and applications of Antonites-balsam, which was the first transdermal therapeutic system (TTS) in medical history.[25] These medical recipes have been lost to time, though some recorded treatments still remain.[29] After 1130, the monks were no longer permitted to perform operations, and so barber surgeons were employed to remove gangrenous limbs and treat open sores.[29] Three barbers founded a hospital in Memmingen in 1214 and accepted those who were afflicted with the gangrenous form of ergotism. Patients were fed and housed, with the more able-bodied individuals acting as orderlies and assistants. Patients with the convulsive form of ergotism, or ergotismus convulsivus, were welcomed for only nine days before they were asked to leave, as convulsive ergotism was seen as less detrimental. Though the sufferers often experienced irreversible effects, they most often returned to their families and resumed their livelihoods.[29]

An important aspect to the Order of St. Anthony's treatment practices was the exclusion of rye bread and other ergot-containing edibles, which halted the progression of ergotism.[26] There was no known cure for ergotism itself; however, there was treatment of the symptoms, which often included blood constriction, nervous disorders and/or hallucinations; if the sufferer survived the initial poisoning, his limbs would often fall off, and he or she would continue to improve in health if he or she halted consumption of ergot.[27] The trunk of the body remained relatively untouched by the disease until its final stages, and the victims, not understanding the cause of their ailment, would continue to imbibe ergot-laden food for weeks until the condition reached their digestive system.[29] It is believed that the peasantry and children were most susceptible to ergotism, though the wealthy were afflicted as well, as, at times, entire villages relied on tainted crops for sustenance, and during times of famine, ergotism reached into every house.[25] Ergot fungus is impervious to heat and water, and thus it was most often baked into bread through rye flour; though other grasses can be infected, it was uncommon in Medieval Europe to consume grasses other than rye.[26] The physiological effects of ergot depended on the concentration and combinations of the ingested ergot metabolites, as well as the age and nutritional status of the afflicted individual.[24] The Antonites began to decline after physicians discovered the genesis of ergotism and recommended methods for removing the sclerotium from the rye crops. In 1776, the cloisters of the Antonites were incorporated into the Maltese Knights Hospitaller, losing much of their medical histories in the process and losing the ergotism cures and recipes due to lack of use and lack of preservation.[29]

Usage in gynaecology and obstetrics

[edit]

Midwives and very few doctors in Europe have used extracts from ergot for centuries:

  1. In a Nuremberg manuscript of 1474, powdered ergot was prescribed together with Laurel-fruits and rhizomes of Solomon's seals to cure permutter or heffmutter, which refers to pain in the lower abdomen caused by 'uprising of the womb'[30]
  2. In a printed book of 1582, the German physician Adam Lonicer wrote, that three sclerotia of ergot, used several times a day, were used by midwives as a good remedy in case of the "uprising and pain of the womb" (auffſteigen vnd wehethumb der mutter)[31]
  3. Joachim Camerarius the Younger wrote in 1586, that sclerotia of ergot held under the tongue, would stop bleeding[32]

To prove that ergot is a harmless sort of grain, in 1774, the French pharmacist Antoine-Augustin Parmentier edited a letter he had received from Madame Dupile, a midwife of Chaumont-en-Vexin. She had told him that if uterine contractions were too weak in the expulsion stage of childbirth, she and her mother gave peeled ergot in an amount of the filling of a thimble dispersed in water, wine or broth. The administration of ergot was followed by a mild childbirth within 15 minutes.[33] The French physician Jean-Baptiste Desgranges (1751–1831) published in 1818, that in 1777 he had met midwives in Lyon, who successfully treated feeble uterine contractions by administering the powder of ergot. Desgranges added this remedy to his therapeutic arsenal. From 1777 to 1804, he was successful in alleviating childbirth for more than twenty women by the administration of the powder of ergot. He never saw any side-effect of this treatment.[34]

In the United States, in 1807 Dr. John Stearns of Saratoga County, New York wrote to a friend that he had used, over several years, a pulvis parturiens with complete success in patients with "lingering parturitation". This pulvis parturiens consisted of ergot, that he called a "spurious groth of rye". He boiled "half a drachm" (ca. 2g) of that powder in half a pint of water and gave one third every twenty minutes, till the pains commenced.[35] In 1813, Dr. Oliver Prescott (1762–1827) of Newburyport, Massachusetts published a dissertation "on the natural history and medical effects of the secale cornutum", in which he described and analysed the experience he had gathered over five years while using ergot in cases of poor uterine action in the second stage of labour in childbirth.[35]

The 1836 Dispensatory of the United States recommended "to a woman in labour fifteen or twenty grains [ca. 1 to 1.3g] of ergot in powder to be repeated every twenty minutes, till its peculiar effects are experienced, or till the amount of a drachm [ca. 3.9g] has been taken".[36]

In 1837, the French Codex Pharmacopee Francaise required ergot to be kept in all pharmacies.[37]

Low to very low evidence from clinical trials suggests that prophylactic use of ergot alkaloids, administered by intravenous (IV) or intramuscular (IM) in the third stage of labor, may reduce blood loss and may reduce the risk of moderate to severe hemorrhage following delivery, however this medication may also be associated with higher blood pressure and higher pain.[38] It is not clear if oral ergot alkaloids are beneficial or harmful as they have not been well studied.[38] A 2018 Cochrane Systematic Review concluded that other medications such as oxytocin, syntometrine and prostaglandins, may be preferred over ergot alkaloids.[38]

Though ergot was known to cause abortions in cattle and humans, this was not a recognized use for it as abortion was illegal in most countries, thus evidence for its use in abortion is unknown.[24] Most often, ergot was used to speed the process of parturition or delivery, and was not used for the purpose of halting postpartum bleeding, which is a concern of childbirth.[27] However, until anesthesia became available, there was no antidote or way of controlling the effects of ergot. So if the fetus did not move as expected, the drug could cause the uterus to mold itself around the child, rupturing the uterus and killing the child. David Hosack, an American physician, noted the large number of stillbirths resulting from ergot use and stated that rather than pulvis ad partum, it should be called pulvis ad mortem.[27] He began advocating for its use to halt postpartum bleeding. Eventually, doctors determined that the use of ergot in childbirth without an antidote was too dangerous. They ultimately restricted its use to expelling the placenta or stopping hemorrhage. Not only did it constrict the uterus, ergot had the ability to increase or decrease blood pressure, induce hypothermia and emesis, and influence pituitary hormone secretions.[24] In 1926, Swiss psychiatrist Hans Maier suggested to use ergotamine for the treatment of vascular headaches of the migraine type.[16]

In the 1930s, abortifacient drugs were marketed to women by various companies under various names such as Molex pills and Cote pills. Since birth control devices and abortifacients were illegal to market and sell at the time, they were offered to women who were "delayed". The recommended dosage was seven grains of ergotin a day. According to the United States Federal Trade Commission (FTC)[39] these pills contained ergotin, aloes, Black Hellebore and other substances. The efficacy and safety of these pills are unknown. The FTC deemed them unsafe and ineffective and demanded that they cease and desist selling the product. Currently, over a thousand compounds have been derived from ergot ingredients.[16]

Speculated cause of hysterics and hallucinations

[edit]

It has been posited that Kykeon, the beverage consumed by participants in the ancient Greek Eleusinian Mysteries cult, might have been based on hallucinogens from ergotamine, a precursor to the potent hallucinogen LSD, and ergonovine.[16][40][41]

An article appearing in the July 23, 1881 edition of Scientific American entitled "A New Exhilarating Substance" denotes cases of euphoria upon consuming tincture of ergot of rye, particularly when mixed with phosphate of soda and sweetened water. In rainy years, it was thought rye bread exceeded 5% ergot.[42]

British author John Grigsby contends that the presence of ergot in the stomachs of some of the so-called 'bog-bodies' (Iron Age human remains from peat bogs of northeast Europe, such as the Tollund Man) is indicative of use of Claviceps purpurea in ritual drinks in a prehistoric fertility cult akin to the Greek Eleusinian Mysteries. In his 2005 book Beowulf and Grendel, he argues that the Anglo-Saxon poem Beowulf is based on a memory of the quelling of this fertility cult by followers of Odin. He writes that Beowulf, which he translates as barley-wolf, suggests a connection to ergot which in German was known as the 'tooth of the wolf'.[43]

Linnda R. Caporael posited in 1976 that the hysterical symptoms of young women that had spurred the Salem witch trials had been the result of consuming ergot-tainted rye.[44] However, Nicholas P. Spanos and Jack Gottlieb, after a review of the historical and medical evidence, later disputed her conclusions.[45] Other authors have likewise cast doubt on ergotism as the cause of the Salem witch trials.[46]

Claviceps purpurea

[edit]

Mankind has known about Claviceps purpurea for a long time, and its appearance has been linked to extremely cold winters that were followed by rainy summers.[citation needed]

The sclerotial stage of C. purpurea conspicuous on the heads of ryes and other such grains is known as ergot. Favorable temperatures for growth are in the range of 18–30 °C. Temperatures above 37 °C cause rapid germination of conidia.[citation needed] Sunlight has a chromogenic effect on the mycelium, with intense coloration.[citation needed] Cereal mashes and sprouted rye are suitable substrates for growth of the fungus in the laboratory.[citation needed]

Claviceps africana

[edit]

Claviceps africana infects sorghum. In sorghum and pearl millet, ergot became a problem when growers adopted hybrid technology, which increased host susceptibility.[16] It only infects unfertilized ovaries, so self-pollination and fertilization can decrease the presence of the disease, but male-sterile lines are extremely vulnerable to infection.[citation needed] Symptoms of infection by C. africana include the secretion of honeydew (a fluid with high concentrates of sugar and conidia), which attracts insects like flies, beetles and wasps that feed on it. This helps spread the fungus to uninfected plants.

In Sorghum, this honeydew can be spotted coming out of head flowers. A whitish sticky substance can also be observed on leaves and on the ground.[47]

C. africana caused ergot disease that caused a famine in 1903–1906 in northern Cameroon, West Africa, and also occurs in eastern and southern Africa, especially Zimbabwe and South Africa. Male sterile sorghums (also referred to as A-lines) are especially susceptible to infection, as first recognized in the 1960s, and massive losses in seed yield have been noted. Infection is associated with cold night temperatures that are below 12 °C occurring two to three weeks before flowering.[citation needed]

Sorghum ergot caused by Claviceps africana Frederickson, Mantle and De Milliano is widespread in all sorghum-growing areas, whereas the species was formerly restricted to Africa and Asia where it was first recorded more than 90 years ago, it has been spreading rapidly and by the mid-1990s it reached Brazil, South Africa and Australia. By 1997, the disease had spread to most South American countries and the Caribbean including Mexico, and by 1997 had reached Texas in the United States.[16]

Management

[edit]

Partners of the CABI-led programme, Plantwise (including the Ministry of Agriculture and Livestock in Zambia) have several recommendations for managing the spread of ergot, these include; planting tolerant varieties, disk fields after harvest to prevent sorghum ratoon and volunteer plants from developing, remove any infected plants, and carrying out three-year crop rotations with legumes.[47]

[edit]

Periglandula are a genus of fungi in the family Clavicipitaceae.

Ipomoea asarifolia, and Ipomoea tricolor seeds contains LSA and LSH among other alkaloids, due to the presence of the symbiotic fungus Periglandula ipomoeae, which lives symbiotically with them as an epibiont and produces these compounds[48][49][50]

See also

[edit]

Sources

[edit]

 This article incorporates text from a free content work. Licensed under CC-BY-SA (license statement/permission). Text taken from PMDG: Ergot sugary disease in sorghum​, CABI.

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Ergot is a fungal primarily affecting crops and grasses, caused by of the Claviceps, with being the most common in temperate regions, where it infects the ovaries of host plants and replaces developing seeds with elongated, dark-purple sclerotia containing toxic alkaloids. These sclerotia, which resemble rooster spurs—hence the name "ergot" from the word for spur—can survive in soil or contaminated grain for years, serving as the primary inoculum for new infections. The disease impacts over 400 grass , including , , , and , leading to yield losses and contamination risks in . The life cycle of C. purpurea involves sclerotia germinating in spring to produce ascospores that infect flowering host plants, leading to honeydew production and eventual sclerotia formation, thriving in cool, humid conditions; other like C. africana in primarily rely on asexual conidial spread, with a sexual stage described but rarely observed. Historically, ergot has caused devastating outbreaks of in humans and through consumption of contaminated , manifesting as convulsive or gangrenous syndromes known as "." Epidemics ravaged medieval Europe, with estimates of 20,000 to 50,000 deaths in between 900 and 1300 AD, and it has been hypothesized to contribute to events such as the weakening of Julius Caesar's legions during his campaigns in (a speculative connection) and the strange behavior during the 1692 , where symptoms mimicked bewitchment (though this theory is controversial). In animals, ergot poisoning leads to reproductive issues, lameness, and , prompting strict regulatory limits on sclerotia in feed. Ergot sclerotia produce over 50 alkaloids, including ergotamine, ergometrine, and lysergic acid derivatives, which are responsible for both toxicity and therapeutic applications. Medically, ergot alkaloids like ergotamine and dihydroergotamine are used to treat acute migraine headaches by constricting cranial blood vessels, while methylergonovine (a semi-synthetic derivative) prevents postpartum hemorrhage by inducing uterine contractions. Lysergic acid from ergot served as the precursor for lysergic acid diethylamide (LSD), first synthesized in 1938, highlighting its role in pharmacology despite risks of ergotism from overdose or contamination. Historically, ergot was employed in obstetrics from the 18th century to control uterine bleeding, though its use was regulated after reports of toxicity.

Definition and Taxonomy

General Description

Ergot is the for fungi belonging to the genus Claviceps, which is classified within the phylum Ascomycota and the order . These obligate parasitic fungi primarily infect the inflorescences of grasses and cereal crops, such as , , and , where they develop within the ovaries of host plants. The most distinctive structure of Claviceps species is the , a compact, dormant resting body that forms in place of infected . This hard, elongated structure is typically dark to , measuring up to 5 cm in length depending on the host seed size, and consists of a pigmented outer rind surrounding internal fungal tissue. The sclerotium contains ergot alkaloids, secondary metabolites that contribute to its toxicity. It is essential to differentiate ergot as the fungal organism from , the mycotoxicosis resulting from ingestion of -contaminated grains, and from ergot alkaloids, the specific neurotoxic compounds produced by these fungi. Morphologically, Claviceps features ascocarps in the form of perithecia that develop on the surface under suitable conditions; these flask-shaped structures house asci, each producing eight elongated ascospores. As a key , ergot significantly impacts production through kernel replacement and accumulation.

Etymology and Classification

The term "ergot" originates from the word ergot, meaning "spur," specifically referring to the spur-like projection on a rooster's foot, a descriptor applied to the hardened, elongated sclerotia produced by the due to their resemblance in shape. This highlights the visible pathology on infected grains, and the term entered English usage in , marking its early recognition in . The taxonomic history of ergot fungi traces back to pre-Linnaean classifications, where they were variably placed in genera such as Sclerotium clavus or Spermoedia clavus based on morphological observations of their sclerotial forms. In 1853, French mycologist Louis René Tulasne formally established the genus Claviceps within the Ascomycota phylum, initially describing three species and emphasizing their parasitic nature on grass ovaries; today, the genus encompasses over 60 recognized species. Recent multigene phylogenetic analyses have further refined the classification by dividing the genus into four infrageneric sections—Claviceps, Citrinae, Paspalorum, and Pusillae—based on morphological, host-specific, and molecular data, with Claviceps purpurea remaining the type species. Classification within the genus Claviceps relies on key diagnostic traits, including endophytic growth within host plant ovaries, the development of a distinctive sphacelial stage characterized by honeydew-like exudate, and the production of ergot alkaloids as secondary metabolites. These features distinguish ergot fungi from other grass pathogens, with endophytic colonization enabling systemic infection and the sphacelial phase facilitating spore dispersal, while alkaloid synthesis serves as a chemical marker for identification in phylogenetic studies. Phylogenetically, Claviceps is positioned within the family Clavicipitaceae in the order of the , forming a monophyletic closely related to entomopathogenic fungi such as those in the genera Cordyceps and Epichloë. This placement underscores shared evolutionary adaptations for host manipulation and toxin production, with molecular analyses of rDNA and mitochondrial genes confirming the genus's divergence from broader fungal lineages around 30-50 million years ago.

Biology

Life Cycle

The life cycle of ergot fungi, primarily exemplified by , is an annual process adapted to cool-temperate climates and involves distinct phases of , vegetative growth, , and spore dispersal on host grasses and cereals. This cycle ensures survival through overwintering structures and relies on specific environmental cues for progression, typically spanning from spring to sclerotial maturation within 4-6 weeks. The phase begins in spring when wind-dispersed ascospores, the primary inoculum, land on the receptive stigmas of flowering host plants such as or other grasses during . These ascospores germinate rapidly within 24 hours under moist conditions, producing germ tubes that penetrate the stigmatic surface without specialized infection structures, followed by hyphal growth down the style to colonize the developing . This initial colonization mimics successful , allowing the fungus to establish within the floral tissues. Following , the enters the sphacelium development , where extensive hyphal proliferation forms a white, spongy mycelial mass within the , often referred to as the sphacelial . Around 5-7 days post-, this sphacelium produces copious conidia embedded in a sticky, sugary known as honeydew, which oozes from the infected floret and facilitates secondary spread through splash, , or vectors like flies. The honeydew can persist for several days, amplifying local infections before transitioning to . As the infection progresses, the sphacelium differentiates into sclerotia, hard, elongated, purplish-black resting bodies that replace the seed, consuming the ovary's contents over 3-5 weeks. These sclerotia, measuring 1-5 cm in length in , feature a protective outer cortex and serve as the overwintering survival structures, persisting in , on debris, or incorporated into harvested . Sclerotial formation is triggered by environmental factors like decreasing and culminates in the release of the host from further colonization. In the subsequent spring, sclerotia germinate after a period of at 0-10°C for at least 25 days (typically 4-8 weeks), producing elongated stromata topped with perithecia under cool, moist conditions. Within the perithecia, linear asci develop and discharge ascospores forcibly into the air, restarting the cycle on nearby susceptible hosts. This dispersal phase completes the annual life cycle, with the entire process from infection to new spore release typically requiring one .

Evolution and Reproduction

The ergot fungi, belonging to the genus Claviceps within the family Clavicipitaceae, trace their evolutionary origins to the Early Cretaceous period, approximately 100 million years ago, when they began co-evolving with early grasses (Poaceae). Fossil evidence from Myanmar amber reveals the oldest known ergot-like sclerotium, Palaeoclaviceps parasiticus, infecting a grass floret dated to 97–110 million years ago, indicating that plant parasitism in Clavicipitaceae predated shifts to other hosts and coincided with the diversification of graminicolous lifestyles. This symbiosis likely arose in Asia during the mid- to Late Jurassic, with the fungi adapting from ancestral insect parasitism to specialized ovarian infection of grasses, facilitating long-distance dispersal via windborne spores. Ergot fungi employ dual reproductive strategies to balance local proliferation and broader dissemination. Sexual reproduction occurs through within perithecia embedded in sclerotia, producing ascospores that serve as primary inocula for infecting new host flowers, promoting and via multiple that enhance population diversity. Asexual reproduction involves conidia released in sticky honeydew from the sphacelial stage, enabling short-range spread by rain splash or within infected fields. This outcrossing mechanism maintains high genetic variability, as evidenced by low in natural populations, allowing to diverse grass hosts. Key adaptations in ergot evolution include the production of ergot alkaloids, which deter herbivory and protect sclerotia from predation during dormancy, with structural diversity arising from expansions and neofunctionalization. has played a role in acquiring synthesis capabilities, with ergot alkaloid s likely originating in and transferring to Clavicipitaceae, enabling rapid evolutionary innovation in . These traits underscore the fungi's success as parasites, integrating reproduction with host-specific survival strategies.

Major Species

Claviceps purpurea

is the primary fungal species responsible for ergot disease in temperate cereal crops, particularly affecting cool-season grasses in regions with moderate climates. This ascomycete fungus belongs to the family Clavicipitaceae and is characterized by its ability to infect the ovaries of host plants, replacing developing seeds with durable resting structures known as sclerotia. The species is notorious for its impact on production, where severe infections can lead to complete replacement of seeds in affected florets, resulting in yield losses approaching 100% in heavily infested fields. The morphology of C. purpurea includes distinctive sclerotia that serve as the overwintering stage, measuring 1-5 cm in length and exhibiting a purple-black coloration with a hard outer rind. These elongated, cylindrical structures, often curved and pointed at the ends, protrude from the host inflorescences and contain the fungal . Upon in suitable conditions, sclerotia produce ascocarps (perithecia) embedded in stromata, from which filiform ascospores are released; these ascospores are , septate, and measure 50-100 μm in length by 1-2 μm in width. Ascospores are forcibly discharged and serve as the primary inoculum for infecting new host flowers. Primary hosts for C. purpurea include cool-season cereal grasses such as (Secale cereale), (Triticum aestivum), and (Hordeum vulgare), with infection occurring specifically during the stage when flowers are open and stigmas are receptive. The fungus enters through the floral tissues, colonizing the and preventing development while promoting sclerotial formation. This host specificity is more pronounced in temperate environments, where the pathogen exploits the flowering periods of these crops. Geographically, C. purpurea is widespread across temperate zones, with significant prevalence in Europe and North America, thriving in humid, cool climates with temperatures ranging from 10-25°C optimal for sclerotial germination and ascospore release. These conditions facilitate the pathogen's lifecycle, particularly in areas with prolonged cool, wet springs that coincide with host anthesis. A unique trait of C. purpurea is its production of a diverse array of ergot alkaloids, with ergotamine being the dominant compound in sclerotia, contributing to its notoriety beyond mere yield impacts. The general life cycle involves ascospore infection followed by conidial spread within the host, though detailed aspects are covered elsewhere.

Claviceps africana

Claviceps africana is a of ergot primarily known for causing sorghum ergot, a destructive disease in tropical and subtropical regions. First described in 1991 from specimens collected in , it was distinguished from the related Claviceps sorghi based on its unique sexual stage, morphology, and profile. Unlike the temperate , C. africana exhibits adaptations suited to warmer climates and has a narrower host range focused on crops. This poses significant threats to sorghum production due to its ability to cause rapid outbreaks under favorable conditions. The morphology of C. africana features a prominent honeydew stage, where infected florets exude a sticky, sugary containing macroconidia and microconidia. Macroconidia are , oblong to , measuring approximately 15 × 7 μm, and play a role in short-distance spread, often facilitated by attracted to the honeydew. Sclerotia, the overwintering structures, are smaller than those of many ergot species, typically 0.5-2 cm in length, conical in shape, hard, and black to purple, often partially covered by white sphacelial tissue. These sclerotia develop from the honeydew stage and serve as the primary inoculum for new infections. C. africana primarily infects sorghum (Sorghum bicolor) and sudangrass (Sorghum × drummondii), targeting unfertilized ovaries in florets during periods of high , which facilitates and penetration. Infection occurs when conidia from honeydew or sclerotia land on open florets, leading to replacement of the grain with fungal tissue. While it can occasionally affect other grasses like , its host specificity makes it a major concern for sorghum-based agriculture. Geographically, C. africana is prevalent in , where it originated, as well as , the (including the , , and ), and . It thrives in temperatures of 25-35°C and rainy conditions that promote humidity above 90%, enabling explosive epidemics; for instance, it spread across 16,000 km² in within one week in 1996. In regions like and , infection rates can reach up to 80% in susceptible hybrid varieties, causing substantial yield losses. A key unique trait of C. africana is its capacity for rapid development driven by high conidial production in the honeydew, with microconidia enabling wind dispersal over moderate distances. It produces lower levels of certain ergot alkaloids compared to C. purpurea, primarily dihydroergosine and related dihydrogenated tripeptides rather than derivatives, which influences its toxicity profile. These characteristics, combined with its reliance on environmental cues for sporulation, underscore its to tropical agroecosystems.

Ecology and Plant Pathology

Host Interactions and Symptoms

Ergot fungi, primarily species in the genus Claviceps, establish a biotrophic relationship with host by infecting the floral tissues, particularly the ovaries of grasses and cereals. The infection begins when ascospores, released from mature sclerotia, germinate on the stigmatic surface of unfertilized flowers, typically within 24 hours under favorable cool and moist conditions. Hyphae from these germinated spores penetrate the style and colonize the wall, growing intercellularly without causing immediate to maintain host viability. As the fungus proliferates, it diverts nutrients from the developing to support its own growth, effectively hijacking the plant's reproductive resources and preventing normal grain formation. Visible symptoms of ergot emerge shortly after . In the initial stage, infected ovaries produce a sticky, yellowish known as honeydew, which consists of a conidial mass that oozes from the florets and can cover the . This honeydew serves as a secondary inoculum source. As the infection progresses, the replaces the developing with hard, elongated sclerotia—purplish-black fungal survival structures that can measure 1–5 cm in length in hosts like . In severe infections, the replacement of seeds with sclerotia leads to reduced in affected tillers due to disrupted floral development and . Host plants mount defense responses to ergot , though these are often insufficient to halt the biotrophic . Rye and other cereals produce compounds, such as hydroxamic acids (e.g., 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one), which exhibit phytoalexin-like activity by inhibiting fungal growth; however, the suppresses these responses through secreted effectors that manipulate host . Additional plant defenses include rapid stigma senescence post-pollination and physical barriers like callose deposition, but cool, wet weather that delays fertilization can overwhelm these mechanisms, increasing susceptibility. Ergot typically causes yield losses of 5–10% in small cereals by replacing kernels with non-harvestable sclerotia, though losses can exceed 50% in hybrid seed production fields for crops like . Secondary spread of ergot is facilitated by environmental and biological vectors. Rain splash dislodges conidia from honeydew, disseminating them to nearby flowers, while insects such as flies and are attracted to the sugary and mechanically transfer conidia between plants or fields. Wind can also aid in dispersing ascospores over longer distances from overwintered sclerotia. These vectors amplify within and across host populations, particularly in dense stands.

Global Distribution

Ergot fungi, primarily species of the genus Claviceps, exhibit a global distribution shaped by climatic conditions, host availability, and human activities such as and . In temperate zones, Claviceps purpurea predominates, infecting a wide range of grasses and cereals across cooler regions. This is widespread in , where it frequently causes outbreaks in cereal crops; for instance, ergot sclerotia have been detected in shipments from , highlighting ongoing concerns in major grain-producing areas. In , C. purpurea is common in the northern two-thirds of the continent, with notable epidemics reported in the Canadian prairies, including significant incidences in 1999 (affecting 12% of Canadian Western Red Spring wheat samples), 2005, 2008, and 2011. In , C. purpurea has been documented in belts, such as southwestern China, where it was first reported causing ergot disease on Triticum aestivum in 2022, indicating its establishment in key agricultural regions. In tropical and subtropical regions, Claviceps africana is the primary ergot pathogen, particularly on and related grasses. This species is endemic to , with infections prevalent in sorghum fields, including those in where it poses challenges to local production. C. africana has spread to , where it is widely distributed across sorghum-growing areas, and to , affecting crops in multiple states. In the United States, it is emerging in southern regions, with detections in states like , signaling potential expansion into warmer production zones. The global distribution of ergot is influenced by environmental and anthropogenic factors. , characterized by rising temperatures, alternating periods of intense rainfall and drought, is promoting fungal growth and expanding ranges; for example, warmer conditions have increased ergot occurrence in previously less affected areas like . Additionally, facilitates the spread of sclerotia, the durable resting structures of the , which contaminate seed lots and enable rapid dissemination to new continents, as seen with C. africana moving from to the and within years. Ergot infections pose a substantial threat to cereal production worldwide, typically causing yield losses of 5–10% in affected small grain cereals, though losses can exceed 50% in hybrid seed production fields for crops like sorghum. The Food and Agriculture Organization (FAO) of the United Nations monitors ergot and related mycotoxins through guidelines on good agricultural and manufacturing practices to mitigate risks in international grain trade. In the European Union, the maximum limit for ergot sclerotia in unprocessed rye was reduced to 0.2 g/kg effective July 1, 2025, to further mitigate risks in grain trade.

Ergot Alkaloids

Chemical Structure and Types

Ergot alkaloids constitute a diverse group of alkaloids defined by a core tetracyclic ring system, which forms the foundational scaffold for their . This arises from the condensation of L-tryptophan and dimethylallyl diphosphate, yielding a fused and quinoline-like framework with nitrogen atoms at key positions. Over 90 distinct ergot alkaloids have been identified across various fungal species, reflecting significant structural variability through modifications such as , , and peptide attachments at the core. These compounds typically accumulate in sclerotia at concentrations ranging from 0.01% to 0.50% of dry weight, varying by fungal strain, host plant, and environmental conditions. Ergot alkaloids are broadly classified into three structural types: clavines, simple lysergic acid derivatives (including amides), and ergopeptines. Clavines, such as agroclavine, feature relatively simple, partially saturated rings and serve as biosynthetic precursors. Lysergic acid amides, exemplified by ergometrine, involve amide linkages to the moiety derived from the core. Ergopeptines, like ergotamine (molecular formula C33H35N5O5), are complex derivatives incorporating a cyclol-containing attached to the nucleus. Analytical identification and quantification of these alkaloids rely on techniques such as (HPLC), often coupled with fluorescence or detection for separation and structural confirmation.

Biosynthesis and Production

The biosynthesis of ergot alkaloids in fungi such as begins with the of L-tryptophan by dimethylallyltryptophan (DMATS), an encoded by the dmaW , which catalyzes the attachment of a dimethylallyl group to form dimethylallyl-L-tryptophan (DMAT). This initial step is followed by N-methylation of DMAT by EasF (a methyltransferase) and subsequent and via EasC and EasE, leading to the early intermediate chanoclavine-I. Chanoclavine-I is then oxidized by EasD (an oxidoreductase) to chanoclavine-I aldehyde, which serves as a for further diversification into clavine alkaloids, derivatives, or ergopeptines through additional enzymatic modifications within the pathway. The core genetic machinery for ergot alkaloid synthesis is organized in the ergot alkaloid synthesis (eas) gene cluster, which encompasses dmaW along with downstream genes such as easA (encoding a reductase/ that directs pathway branching), easF, easE, easC, and easD. This cluster, typically comprising 8-14 genes depending on the fungal , enables the production of a range of alkaloids and is conserved across ergot-producing ascomycetes. Expression of the eas cluster and associated genes like dmaW is regulated by environmental cues, including and availability; for instance, optimal alkaloid yields in fungal cultures occur at slightly acidic (around 5-6) and under nitrogen-limited conditions that promote . In natural infections, ergot alkaloids are primarily synthesized and accumulated in the sclerotia, the dormant resting structures formed within the ovaries of host plants during the later stages of fungal colonization. Production levels are influenced by the host species, with rye (Secale cereale) showing greater susceptibility to infection than (Triticum aestivum), leading to higher overall contamination; alkaloid contents can exceed 1-2 mg/g dry mass in sclerotia. For industrial production, ergot alkaloids are obtained through submerged fermentation of Claviceps strains, such as mutants of C. purpurea or C. paspali, in bioreactors optimized for nutrient composition and aeration. These processes yield 1-2 g/L of total alkaloids, primarily ergopeptines like ergotamine, under controlled conditions that mimic sclerotial development, including phosphorus and sucrose supplementation. Genetic engineering of the eas cluster has further enhanced yields in heterologous hosts like yeast, though fungal fermentation remains the primary method for pharmaceutical-grade production. Recent advances include the 2022 reconstitution of the complete D-lysergic acid biosynthetic pathway in Saccharomyces cerevisiae, enabling scalable production, and the 2024 identification of the easR gene as a key regulator in Metarhizium species, offering new targets for pathway optimization.

Effects on Animals and Humans

Ergotism and Toxicity

Ergotism, also known as ergot poisoning, refers to the pathological condition resulting from excessive exposure to ergot alkaloids produced by fungi such as Claviceps purpurea. It manifests primarily in two forms: gangrenous ergotism, characterized by severe vasoconstriction leading to tissue ischemia and potential limb loss, and convulsive ergotism, involving neurological disturbances such as seizures and hallucinations. These effects arise from the ingestion of contaminated grains or feed, with historical and modern cases linked to rye and other cereals. The mechanisms of ergotism involve the binding of ergot alkaloids to receptors in mammals, including serotonergic (5-HT), (D2), and adrenergic (α) receptors, where they act as partial agonists or antagonists. For instance, ergotamine primarily induces by activating 5-HT1B/1D and α-adrenergic receptors, reducing peripheral blood flow and causing ischemic damage. In contrast, ( amide) contributes to neuroexcitation through serotonergic receptor interactions, mimicking and leading to overstimulation. Overall, ergot alkaloids exhibit moderate acute oral toxicity, depending on the specific compound and . Symptoms of gangrenous ergotism include intense burning pain (historically termed ""), swelling, , and dry of extremities such as fingers, toes, ears, or limbs, often accompanied by gastrointestinal distress like , , and . Convulsive ergotism presents with neurological signs including muscle spasms, tremors, , hallucinations, convulsions, and fever, potentially lasting several days. No-observed-adverse-effect levels (NOAELs) for key alkaloids like ergotamine and ergometrine are established at 0.22–0.60 mg/kg body weight per day based on subchronic studies in rats. Regulatory bodies, such as the , have set maximum levels for ergot alkaloids in and feed as of 2024 (e.g., sum of ergot alkaloids ≤1700 µg/kg in unprocessed ) to mitigate risks. These strict regulatory limits (e.g., 0.05–0.3% ergot sclerotia in grains) and inspections of commercial grains ensure that ergot contamination in modern bread products is extremely rare, rendering human ergotism from store-bought rye or pumpernickel bread negligible, with no risk of accidental LSD-like effects. In animals, ergot alkaloids cause significant toxicity, particularly in livestock consuming contaminated forage, leading to production losses estimated at 30–100% reduced weight gain in affected herds. Cattle are especially susceptible, with fescue toxicosis from endophyte-infected tall fescue (Epichloë coenophiala) inducing hyperthermia, lameness, agalactia, rough coats, and reproductive impairments due to vasoconstriction and prolactin suppression. Other species, such as pigs and horses, exhibit similar vasospastic effects, including tail necrosis and reduced feed intake, with NOAELs around 0.15–1.4 mg total ergot alkaloids/kg feed in piglets and poultry.

Medical and Pharmacological Applications

Ergot alkaloids and their derivatives have found significant applications in , particularly in and , due to their vasoconstrictive and properties derived from ergotamine precursors. Ergometrine (also known as ergonovine), a natural ergot , is widely used to control postpartum hemorrhage by inducing strong . Introduced into clinical practice in 1935, it is administered during the third stage of labor to prevent excessive bleeding from , a leading cause of maternal mortality. This agent acts primarily on alpha-adrenergic and serotonin receptors in the , providing rapid onset and sustained contraction without the broader systemic effects seen in crude ergot preparations. In migraine management, ergotamine tartrate, often combined with as in the formulation Cafergot, serves as an acute treatment for moderate to severe attacks by constricting cranial vessels and inhibiting vasogenic . This ergot , derived from sclerotia, was one of the first targeted therapies for vascular headaches, offering relief within hours when taken at the onset of symptoms. A semi-synthetic derivative, (DHE), provides an improved safety profile with reduced nausea and fewer peripheral vasoconstrictive risks, available in , injection, or infusion forms for acute and treatment. DHE's efficacy stems from its selective agonism at 5-HT1B/1D receptors, making it a preferred option for patients unresponsive to . Beyond headache disorders, ergot-derived compounds address other neurological conditions through modulation. , a semi-synthetic ergot , functions as a D2 in the treatment of , helping to alleviate motor symptoms like bradykinesia and rigidity by mimicking endogenous in the . Similarly, , another ergot , has been employed prophylactically for cluster headaches, reducing attack frequency by antagonizing serotonin receptors and stabilizing vascular tone, though its use is limited due to potential fibrotic side effects. These applications highlight the therapeutic versatility of ergot derivatives in targeted receptor pharmacology. Ergot alkaloids also served as precursors for lysergic acid diethylamide (LSD), first synthesized from ergotamine by Albert Hofmann in 1938 at Sandoz Laboratories, with its hallucinogenic effects discovered in 1943. This semi-synthetic compound, initially explored for circulatory and respiratory stimulation, revealed potent hallucinogenic effects and was subsequently investigated in psychiatric research for treating conditions like and anxiety, influencing early studies on serotonin pathways.

Historical Context

Ancient Epidemics and Folklore

One of the earliest documented epidemics of ergotism struck the region of in 994 AD, where contemporary chroniclers reported that over 40,000 people perished from consuming contaminated with the during a period of . This outbreak, recorded by the monk Adhemar de Chabannes in his historical annals, devastated communities in and neighboring , underscoring the vulnerability of rye-dependent populations to the toxin's effects in damp, cool climates conducive to fungal growth. Similar epidemics recurred throughout medieval , often linked to poor harvests and the staple use of , leading to widespread suffering from symptoms such as convulsions and limb . The most notorious form of ergotism, known as gangrenous ergotism, earned the moniker "" in medieval accounts due to the excruciating burning pain and subsequent blackening and loss of extremities it caused, evoking infernal torment. In response to these recurrent crises, the Order of Saint Anthony—also called the Antonites—was established around 1095 in , , by nobleman Gaston of Valloire and his son, with papal approval from Urban II, to provide specialized care for afflicted individuals through hospices that incorporated religious rituals and remedies possibly derived from controlled use of ergot itself. The order's monks, identifiable by their black habits and tau crosses, traveled to treat victims, blending with practical aid, and their efforts helped mitigate some outbreaks by isolating cases and promoting better grain storage. In pre-modern , ergotism was frequently interpreted through a lens, with outbreaks viewed as for communal sins or as curses wrought by , reflecting the era's limited understanding of fungal . For instance, 13th-century Iberian cantigas attributed "St. Martial's fire"—a regional synonym for —to God's punishment, as in accounts where afflicted villagers sought miraculous intervention from saints to avert the "." This perception persisted into the , notably in speculations that convulsive contributed to the mass hysteria of the 1692 , where symptoms like seizures and visions among accusers were hypothesized to stem from contaminated local . Such cultural attributions often amplified social panic, leading to accusations of sorcery rather than recognition of environmental causes.

Modern Discoveries and Uses

In the late , scientific investigation into ergot's bioactive components advanced significantly when French pharmacist Tanret isolated the first crystalline , ergotinine, from ergot in 1875, confirming that these compounds were responsible for the fungus's pharmacological effects. This discovery laid the groundwork for understanding ergot's toxicity and potential therapeutic value, shifting research from empirical observations to chemical analysis. Building on this, in 1918, Swiss chemist Arthur Stoll at Laboratories successfully isolated ergotamine, the first pure peptide from ergot, which proved highly active in and treatment. The 20th century saw further breakthroughs in ergot alkaloid applications. In 1943, , also at , synthesized lysergic acid diethylamide () from ergot-derived while exploring circulatory stimulants, inadvertently discovering its profound psychoactive properties during self-experimentation. Ergot-based drugs gained regulatory traction during the 1950s, with the FDA approving formulations like the ergotamine inhaler Medihaler in 1959 for acute relief, marking a milestone in standardized pharmaceutical use. By the , genomic studies elucidated the pathway, with sequencing of the ergot alkaloid synthesis (eas) in revealing a 68.5 kb region containing nonribosomal peptide synthetase genes essential for alkaloid production. Into the 21st century, research highlighted environmental influences on ergot proliferation, with studies in the linking —characterized by warmer temperatures and erratic rainfall—to increased outbreaks in the , such as high levels of ergot alkaloids detected in cereals from during the 2019 and 2020 harvests. Biotechnological efforts have focused on engineering low-alkaloid strains, including of hybrid cultivars with lower ergot contents while maintaining yield, and genetic modifications in endophytic fungi to minimize in crops. Regulatory frameworks evolved to mitigate risks, with the setting a 0.1% (1 g/kg) limit for sclerotia in unground cereals under Directive 2002/32/EC to protect , later refined in subsequent regulations. Subsequent updates include Regulation (EU) 2021/1399 establishing maximum levels for ergot alkaloids in specific cereals (e.g., 125 µg/kg for unprocessed ), effective from July 2022, and Regulation (EU) 2024/1808 further lowering limits for ergot sclerotia and alkaloids in certain products, effective from January 2025.

Management and Control

Agricultural Strategies

Agricultural strategies for managing ergot focus on integrated practices that disrupt the pathogen's life cycle, particularly by limiting sclerotia survival and ascospore dispersal during crop flowering. These approaches emphasize prevention through cultural methods, as ergot, caused by , thrives in cool, moist conditions and infects open florets of cereal grains and grasses. Effective implementation can significantly reduce incidence, with studies showing substantial reductions in sclerotia contamination via combined tactics. Crop rotation is a foundational strategy to minimize ergot buildup, as sclerotia remain viable in for typically about , though survival can exceed this in favorable conditions. Farmers should avoid planting consecutive susceptible grass crops, such as , , or , and instead incorporate non-host breaks like (e.g., or soybeans) or broadleaf crops (e.g., corn) for at least one to two years. This practice reduces overwintering inoculum and prevents secondary infections from volunteer plants, with research indicating that rotations including non- crops can lower ergot severity in subsequent cereal plantings. While fully resistant varieties do not exist for most cereals, breeding efforts prioritize traits that reduce susceptibility, such as delayed or shorter flowering periods to avoid peak ascospore release. Cultivars with compact florets or closed flowering () limit spore entry, and selecting varieties with rapid can decrease infection rates compared to open-flowering types. For example, in and , varieties exhibiting early closure of florets or escape timing have shown lower ergot incidence in field trials, though ongoing breeding programs continue to refine these characteristics for commercial release. Field practices further mitigate risk by promoting conditions unfavorable to . Using clean, sclerotia-free is essential, as contaminated can introduce the , directly leading to field outbreaks; lots should be and treated if necessary to ensure low levels. applications timed just before or at the onset of can suppress ascospore and reduce sclerotia formation, though efficacy varies with weather and inoculum levels. At harvest, methods aim to dilute or eliminate sclerotia to meet standards and prevent carryover. Grain should be cleaned to keep sclerotia below thresholds, such as <0.05% by weight for wheat, <0.1% for and oats, and <0.3% for rye, as higher levels can render crops unmarketable or toxic for livestock. Separating harvests from field edges, where ergot often concentrates, and using gravity tables or air-screen cleaners can achieve this dilution. Post-harvest, burning crop debris or deeply tilling (>10 cm) to bury sclerotia prevents ascospore production in the following season, with burning shown to reduce viable sclerotia substantially in residue-heavy fields.

Research and Prevention Advances

Recent advances in biological control of ergot have focused on mycoherbicides and antagonistic fungi targeting the sclerotia of . species, such as T. harzianum, T. atroviride, and T. asperellum, exhibit strong antagonistic activity against C. purpurea through mycoparasitism and , inhibiting fungal growth by up to over 100% in some dual culture assays and reducing sclerotia by up to 50-100% . Field applications of these isolates on have demonstrated reduced disease severity, with trends toward lower honeydew production and sclerotia formation in the , positioning -based formulations as promising mycoherbicides for sustainable ergot suppression. Additionally, biocontrol agents like species have been investigated for their ability to degrade ergot sclerotia and alkaloids, such as ergotamine, thereby delaying and reducing inoculum levels in soil. Genetic research has leveraged / technology to engineer toxin-free strains of C. purpurea by targeting ergot synthesis (eas) s. Since 2020, studies have established efficient / ribonucleoprotein systems achieving 50-100% editing efficiency through , enabling precise knockouts without off-target effects. A key application involved disrupting the easA , which completely halted production of ergot like ergocristine, creating non-toxic mutants suitable for further metabolic engineering or biocontrol studies. Earlier work in 2021 validated the system by editing s such as pyr4 and trpE, resulting in auxotrophic mutants with reduced , paving the way for trials aimed at developing strains incapable of toxin biosynthesis while maintaining fungal viability. Monitoring technologies have advanced with and AI-driven predictive models to enable early ergot detection and outbreak forecasting. in the near-infrared range, often deployed via drones or online grain sorting systems, detects ergot bodies in cereals by analyzing signatures, achieving accurate quantification at the particle level with multivariate image analysis. These non-destructive methods allow for rapid screening during , identifying as low as 0.1% ergot bodies. For prediction, and models integrate weather data—such as temperature, humidity, and rainfall—with historical outbreak records to forecast ergot incidence, improving accuracy when environmental variables are incorporated. Such AI approaches have shown promise in modeling fungal dynamics, including ergot, by simulating sclerotia risks under varying conditions. Policy frameworks emphasize international standards and climate-resilient practices to mitigate ergot risks. The Commission sets a maximum level of 0.05% ergot sclerotia in and other s to protect , with ongoing efforts to establish specific limits for ergot alkaloids based on toxicological . In the , global policies have prioritized climate-resilient , incorporating ergot management through adaptive strategies like diversified cropping and enhanced monitoring to counter increased outbreak potential from warmer, wetter conditions. Recent developments include EU maximum levels for ergot alkaloids in unprocessed cereals (e.g., 250 µg/kg for , 500 µg/kg for , effective from July 2022) and a 2025 review by the UK's AHDB strengthening management guidelines for ergot in cereals. These initiatives promote integrated approaches that align disease control with broader goals in cereal production.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.